All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
| FENC / Fennec Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| IL0011177958 / Intec Pharma Ltd
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| / Immunomedics, Inc.
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| ECYT / Endocyte, Inc.
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| PCRX / Pacira BioSciences, Inc.
|
|
|
|
|
|
|
|
| TLGT / Teligent Inc
|
|
|
|
|
|
|
|
| TCDA / Tricida Inc
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
| LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
| YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACER / Acer Therapeutics Inc
|
|
|
|
|
|
|
|
| CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
| 71426VAK4 / Pernix Therapeutics Holdings, Inc. Convertible Debt 4.25%
|
|
|
|
|
|
|
|
| ONSIW / Oncobiologics, Inc. Series A Warrant Expiring 2/18/2018
|
|
|
|
|
|
|
|
| ONCS / OncoSec Medical Inc
|
|
|
|
|
|
|
|
| US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
| KOD / Kodiak Sciences Inc.
|
|
|
|
|
|
|
|
| ALLO / Allogene Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OTLK / Outlook Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALIM / Alimera Sciences, Inc.
|
|
|
|
|
|
|
|
| SESN / Sesen Bio Inc.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
| ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc. Call
|
|
|
|
|
|
|
|
| QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
